Printed From BioPortfolio.com
Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process
11:21 EST 16 Nov 2017 | Healio
Scott Gottlieb
WASHINGTON — When diagnosed with Hodgkin lymphoma at the age of 33 years, FDA Commissioner Scott Gottlieb, MD, was told he had a 90% chance of survival.
“Ninety percent doesn’t sound so good if it’s you,” Gottlieb, now 44, told HemOnc Today following a keynote presentation at the Friends of Cancer Research Annual Meeting. “So, to me, that 10% sounded pretty grim.”
Gottlieb — the FDA’s 23rd commissioner — pored over “stacks of studies” in an effort to find available therapy that might improve his chances of
Original Article: Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process
